Recent Finacing
Recent Raise
Hudson River Biotechnology develops CRISPR non‑transgenic genome edits, a nanoparticle delivery platform and SuRE target‑identification to provide molecular breeding and trait‑development services for seed, ornamental, and ingredient producers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
